Focused radiation kept craniopharyngioma tumors in check for years
Original title: Stereotactic radiosurgery offers long-term tumor control for craniopharyngioma: a multi-institutional analysis of clinical and imaging outcomes from the International Radiosurgery Research Foundation (IRRF).
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This treatment is already offered at hospitals today, and this study looked back at people who had it.
The short version
Most people in this study still had their tumor under control 10 years after focused radiation.
What was studied. Doctors looked back at the records of 296 people treated at 13 centers. All of them had craniopharyngioma, a tumor that is not cancer but often grows back. All of them were treated with stereotactic radiosurgery, a focused kind of radiation.
What they found. About 10 years after treatment, the tumor was still under control in 70.1% of people. At 10 years, 85.2% of people were still alive. Vision stayed the same in 86% of people, got better in 10%, and got worse in 4%. Tumors that were part solid and part fluid filled were harder to control than other tumors.
What this means, and what it doesn't
What it could mean: For many people, this focused radiation may hold the tumor steady for a long time. Most people in the study kept their vision. Most also kept their hormone function. If your tumor is part solid and part fluid filled, control may be harder.
What it doesn't mean: This is not a cure and it is not a promise. This was a look back at records of people who were already treated. It was not a new trial comparing this treatment to another one. It does not mean the tumor will never come back. Some tumors in this study did grow again. What happens for you depends on your own tumor and your care team.
Source: PubMed, August 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.